These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26307705)

  • 1. Ion mobility-mass spectrometry-based screening for inhibition of α- synuclein aggregation.
    Liu Y; Graetz M; Ho L; Pukala TL
    Eur J Mass Spectrom (Chichester); 2015; 21(3):255-64. PubMed ID: 26307705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
    Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK
    ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Phycocyanin from Spirulina Inhibits α-Synuclein and Amyloid-β Fibril Formation but Not Amorphous Aggregation.
    Liu Y; Jovcevski B; Pukala TL
    J Nat Prod; 2019 Jan; 82(1):66-73. PubMed ID: 30620188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of α-Synuclein Amyloid Fibril Elongation by Blocking Fibril Ends.
    Shvadchak VV; Afitska K; Yushchenko DA
    Angew Chem Int Ed Engl; 2018 May; 57(20):5690-5694. PubMed ID: 29575453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation.
    Liu Y; Carver JA; Calabrese AN; Pukala TL
    Biochim Biophys Acta; 2014 Sep; 1844(9):1481-5. PubMed ID: 24769497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyphenol Honokiol and Flavone 2',3',4'-Trihydroxyflavone Differentially Interact with α-Synuclein at Distinct Phases of Aggregation.
    Jovcevski B; Das S; Smid S; Pukala TL
    ACS Chem Neurosci; 2020 Dec; 11(24):4469-4477. PubMed ID: 33185419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
    Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA
    J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein Dimers as Potent Inhibitors of Fibrillization.
    Kyriukha YA; Afitska K; Kurochka AS; Sachan S; Galkin M; Yushchenko DA; Shvadchak VV
    J Med Chem; 2019 Nov; 62(22):10342-10351. PubMed ID: 31625739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Pronged Interactions Underlie Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Williams JK; Yang X; Atieh TB; Olson MP; Khare SD; Baum J
    J Mol Biol; 2018 Aug; 430(16):2360-2371. PubMed ID: 29782835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct higher-order α-synuclein oligomers induce intracellular aggregation.
    Illes-Toth E; Ramos MR; Cappai R; Dalton C; Smith DP
    Biochem J; 2015 Jun; 468(3):485-93. PubMed ID: 25851527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein aggregation, seeding and inhibition by scyllo-inositol.
    Ibrahim T; McLaurin J
    Biochem Biophys Res Commun; 2016 Jan; 469(3):529-34. PubMed ID: 26697752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single particle detection and characterization of synuclein co-aggregation.
    Giese A; Bader B; Bieschke J; Schaffar G; Odoy S; Kahle PJ; Haass C; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1202-10. PubMed ID: 15978545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA).
    Herva ME; Zibaee S; Fraser G; Barker RA; Goedert M; Spillantini MG
    J Biol Chem; 2014 Apr; 289(17):11897-11905. PubMed ID: 24584936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a New α-Synuclein Aggregation Inhibitor via Mass Spectrometry Based Screening.
    Xu M; Loa-Kum-Cheung W; Zhang H; Quinn RJ; Mellick GD
    ACS Chem Neurosci; 2019 Jun; 10(6):2683-2691. PubMed ID: 31117342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors.
    Pujols J; Peña-Díaz S; Conde-Giménez M; Pinheiro F; Navarro S; Sancho J; Ventura S
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein.
    Kobayashi M; Kim J; Kobayashi N; Han S; Nakamura C; Ikebukuro K; Sode K
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1139-44. PubMed ID: 16962995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold denaturation of α-synuclein amyloid fibrils.
    Ikenoue T; Lee YH; Kardos J; Saiki M; Yagi H; Kawata Y; Goto Y
    Angew Chem Int Ed Engl; 2014 Jul; 53(30):7799-804. PubMed ID: 24920162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
    FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.